Enno Spillner
Director of Finance/CFO en FORMYCON AG .
Fortuna: 807 244 $ al 31/03/2024
Perfil
En la actualidad, Enno Spillner ocupa el cargo de director financiero de Evotec SE y codirector general de Evotec International GmbH (una filial de Evotec SE). También forma parte del consejo de administración de Nanobiotix SA y Concentro Management AG y es socio gerente de Biom Venture Capital GmbH & Co. Fonds KG. En su anterior carrera, el Sr. Spillner ocupó el cargo de Director Ejecutivo y Financiero de 4SC AG, Director Gerente de Munich Innovative Biomaterials GmbH, Director Gerente de ActiPac Biosystems GmbH y Jefe de Finanzas y Control de BioM AG Munich BioTech Development. Enno Spillner obtuvo un MBA en la Universidad de Bamberg.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
EVOTEC SE
0.03% | 31/12/2022 | 51 655 ( 0.03% ) | 807 244 $ | 31/03/2024 |
Cargos activos de Enno Spillner
Empresas | Cargo | Inicio |
---|---|---|
NANOBIOTIX | Director/Board Member | 18/06/2014 |
FORMYCON AG | Director of Finance/CFO | 01/04/2023 |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program. | Director/Board Member | 11/05/2010 |
Biom Venture Capital GmbH & Co. Fonds KG
Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Biom Venture Capital GmbH & Co. Fonds KG invests in early-stage companies based in the region of Bavaria in Germany focused on life sciences. | Corporate Officer/Principal | 01/09/2001 |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Director/Board Member | - |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Director/Board Member | 01/01/2014 |
Antiguos cargos conocidos de Enno Spillner.
Empresas | Cargo | Fin |
---|---|---|
EVOTEC SE | Director of Finance/CFO | 01/03/2023 |
4SC AG | Chief Executive Officer | 30/06/2016 |
ActiPac Biosystems GmbH | Chief Executive Officer | 01/03/2000 |
░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - |
Formación de Enno Spillner.
University of Bamberg | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 4 |
---|---|
4SC AG | Health Technology |
EVOTEC SE | Health Technology |
NANOBIOTIX | Health Technology |
FORMYCON AG | Health Technology |
Empresas privadas | 8 |
---|---|
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. | Commercial Services |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Euronext Paris SA operates as a stock exchange which provides solutions for regulated stock and derivatives markets in France. Its services include facilitating public offerings, providing trading facilities for cash and derivatives products, and supplying market data. The company was founded on January 20, 1988 and is headquartered in Courbevoie, France. | Finance |
BioM AG Munich BioTech Development
BioM AG Munich BioTech Development Investment ManagersFinance BioM AG Munich BioTech Development (BMBD) is a venture capital firm specialized in the life sciences sector. Located in Martinsried on the outskirts of Munich, BMBD was established in 2002 to manage the investment portfolio of BioM AG, a regional technology transfer and venture capital services company. BioM was created in 1997 following Munich's selection in the Government-sponsored BioRegio Competition, and provides business support services to Munich-based biotechnology companies, focusing on start-ups. BMBD manages the BioM Venture Capital fund. Their clients include regional banks, German and European private equity firms and private individuals. The firm operates in partnership with public entities, in particular the German Federal Ministry of Education and Research (BMBF) and HighTech Gründerfonds (HTGF), a partnership between the Government of Germany, the KfW banking group and leading technology corporations. | Finance |
Biom Venture Capital GmbH & Co. Fonds KG
Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Biom Venture Capital GmbH & Co. Fonds KG invests in early-stage companies based in the region of Bavaria in Germany focused on life sciences. | Finance |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Concentro Management AG is a German company that offers services in corporate development and management. The private company is based in Munich, Germany. The company has offices in Munich, Leipzig, and Stuttgart. The company has supported various insolvency administrators in successful asset transfers and sales of companies. The company has also helped in the age-related succession plan of a shareholder of Ropro Produktions GmbH. Additionally, Concentro Management has increased EBIT and transparency in the group through a comprehensive restructuring program. | Finance |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Pharmaceuticals: MajorHealth Technology leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany. | Health Technology |
ActiPac Biosystems GmbH | |
Munich Innovative Biomaterials GmbH
Munich Innovative Biomaterials GmbH Investment ManagersFinance Munich Innovative Biomaterials GmbH functions as a pension/retirement fund. The private company is based in Munich, Germany. | Finance |
- Bolsa de valores
- Insiders
- Enno Spillner